fbpixel

Our website uses cookies to help enhance your browsing experience. Continue to browse our site if you agree to our use of cookies as described in Unilab's Cookie Policy .

For information on how we protect your privacy, please read our Privacy Policy .

ProglinMet
Formulation
Each film-coated tablet contains:
Vildagliptin 50 mg
Metformin HCl 500 mg

 

Each film-coated tablet contains:
Vildagliptin 50 mg
Metformin HCl 850 mg

 

Each film-coated tablet contains:
Vildagliptin 50 mg
Metformin HCl 1000 mg

Vildagliptin + Metformin HCl

ProglinMet®

Prescription Drug

Indications

For patients with type 2 diabetes mellitus (T2DM):

  • as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets
  • in combination with a sulfonylurea (SU) (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulfonylurea.
  • add-on to insulin as an adjunct to diet and exercise to improve glycemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycemic control.
  • initial therapy in patients with T2DM whose diabetes is not adequately controlled by diet and exercise alone.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.